The Anti-CD30 Brentuximab Vedotin Biosimilar Monoclonal Antibody (HDBS0017) is a cutting-edge tool for researchers studying CD30, a cell surface molecule highly expressed in Hodgkin's lymphoma and other lymphoproliferative disorders. This monoclonal antibody, developed using innovative biosimilar technology, specifically targets the CD30 protein and is validated for use in various immunohistochemistry applications.CD30, a member of the tumor necrosis factor receptor superfamily, is a key player in the pathogenesis of certain lymphomas and autoimmune diseases. The Anti-CD30 Brentuximab Vedotin Biosimilar Monoclonal Antibody provides researchers with a reliable tool for detecting and studying CD30 expression in cancer cells, aiding in the development of targeted therapies for lymphoma and other CD30-related diseases.
Whether you are investigating the role of CD30 in lymphoma pathogenesis or exploring novel treatment strategies, the Anti-CD30 Brentuximab Vedotin Biosimilar Monoclonal Antibody is an invaluable resource for your research needs. Its high specificity and sensitivity make it an essential tool for advancing our understanding of CD30 biology and developing personalized treatments for CD30-positive malignancies.
Product Name:
Brentuximab (Anti-CD30) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0017
Target:
CD30
Host Species:
Chimeric
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
SGN-35, cAC10-Val-Cit-MMAE
Description:
Anti-CD30 (brentuximab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
